You have 9 free searches left this month | for more free features.

Nanoparticle Drug

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,

Not yet recruiting
  • Oral Cancer
  • Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
  • +2 more
  • Cairo, Egypt
    11 Saraya El Manial
Jul 8, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

Suspended
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Breast Cancer Trial in Duarte, Pasadena (drug, other, procedure)

Active, not recruiting
  • Breast Cancer
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +6 more
  • Duarte, California
  • +1 more
Jan 31, 2023

Bone Loss in Jaw Trial in Mansoura (Melatonin gel, Metformin and melatonin gel, gel)

Enrolling by invitation
  • Bone Loss in Jaw
  • Melatonin gel
  • +3 more
  • Mansoura, Dakhlia, Egypt
    Amira R agab AL-agooz
Jun 13, 2023

Magnetic Resonance Imaging Trial in Xinxiang (polysaccharide superparamagnetic iron oxide injection)

Completed
  • Magnetic Resonance Imaging
  • polysaccharide superparamagnetic iron oxide injection
  • Xinxiang, Henan, China
    Xinxiang Central Hospital
Aug 23, 2023

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)

Recruiting
  • Human Immunodeficiency Virus
  • +2 more
  • Seattle, Washington
    UW Positve Research, Harborview Medical Center
May 8, 2023

Skin Cancer Trial (Sunscreen, UV Light)

Not yet recruiting
  • Skin Cancer
  • (no location specified)
Feb 9, 2023

Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

Terminated
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2022

Pancreatic Adenocarcinoma, Resectable Pancreatic Carcinoma Trial in United States (Fluorouracil, Gemcitabine Hydrochloride,

Completed
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Carcinoma
  • Birmingham, Alabama
  • +806 more
Oct 18, 2022

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)

Completed
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Stage III Intrahepatic Cholangiocarcinoma AJCC v7, Stage IIIA Gallbladder Cancer AJCC v7, Stage IIIB Gallbladder Cancer AJCC v7

Completed
  • Stage III Intrahepatic Cholangiocarcinoma AJCC v7
  • +8 more
  • Scottsdale, Arizona
  • +2 more
Jan 5, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

Active, not recruiting
  • HER2-positive Breast Cancer
  • +9 more
  • pertuzumab
  • +3 more
  • Duarte, California
  • +2 more
Mar 17, 2022

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting
  • Gastric Cancer
  • Small-cell Lung Cancer
  • Shanghai, Changning District, 交通大学 邮政编码, China
  • +20 more
Nov 1, 2022

Pancreatic Adenocarcinoma, Unresectable Pancreatic Carcinoma, Stage III Pancreatic Cancer AJCC v6 and v7 Trial in United States

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • +3 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Duarte, California
  • +3 more
Mar 17, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced

Completed
  • Diffuse Intrinsic Pontine Glioma
  • Panobinostat Nanoparticle Formulation MTX110
  • Convection-Enhanced Delivery (CED)
  • San Francisco, California
    University of California, San Francisco
Feb 2, 2022

Ovarian Cancer Trial in Hungary, United Kingdom, United States (EP0057, Olaparib tablets)

Recruiting
  • Ovarian Cancer
  • Lady Lake, Florida
  • +15 more
Mar 29, 2022

Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus

Not yet recruiting
  • Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
  • NAB-Paclitaxel plus Cisplatin
  • Cisplatin plus Epirubicin plus Cyclophosphamide
  • Shanghai, Shanghai, China
    Yian Zhang
Apr 17, 2023